Virtual healthcare during pandemic has won patients over; surveyMost patients who switched to virtual tools like video calls, online chat and apps to talk to their Share XVirtual healthcare during pandemic has won patients over; surveyhttps://pharmaphorum.com/news/virtual-healthcare-during-pandemic-has-won-patients-over-survey/
Coronavirus pharma news roundup – 10/07/20As coronavirus vaccines and treatments advance rapidly through research and development, the world starts to consider what drugs Share XCoronavirus pharma news roundup – 10/07/20https://pharmaphorum.com/r-d/views-analysis-r-d/coronavirus-pharma-news-roundup-10-07-20/
Aetion, Cegedim form transatlantic real-world data allianceHealth tech companies Aetion and Cegedim have agreed to combine their data platforms together, to allow clients to Share XAetion, Cegedim form transatlantic real-world data alliancehttps://pharmaphorum.com/news/aetion-cegedim-form-transatlantic-real-world-data-alliance/
Applying digital health to systemic healthcare challengesThe de-prioritisation of face-to-face interactions between patients and healthcare professionals in the wake of COVID-19’s current emergency has Share XApplying digital health to systemic healthcare challengeshttps://pharmaphorum.com/views-analysis-digital/applying-digital-health-to-systemic-healthcare-challenges/
Applied Biocatalysis Summit 2020Advancing Sustainable, Streamlined API and Chemical Production using Enzyme Engineering & Scalable Biocatalytic Processes The development of enzyme-catalyzed Share XApplied Biocatalysis Summit 2020https://pharmaphorum.com/events/applied-biocatalysis-summit-2020/
AI startup Nucleai has immuno-oncology treatment failures in its sightsIsraeli company Nucleai is putting artificial intelligence to work to discover why so many cancer patients don’t respond Share XAI startup Nucleai has immuno-oncology treatment failures in its sightshttps://pharmaphorum.com/news/ai-startup-nucleai-has-immuno-oncology-treatment-failures-in-its-sights/
Digital techniques could ‘turbocharge’ R&D after COVID-19, say UK chemistry leadersThe UK’s Royal Society of Chemistry has called for digital techniques to be more widely used as part Share XDigital techniques could ‘turbocharge’ R&D after COVID-19, say UK chemistry leadershttps://pharmaphorum.com/news/digital-techniques-could-turbocharge-rd-after-covid-19-say-uk-chemistry-leaders/
Marketing for life science companies – drivers of changeHealthcare’s digital revolution has been transformed into a digital evolution over the last decade and, having redefined the Share XMarketing for life science companies – drivers of changehttps://pharmaphorum.com/views-and-analysis/marketing-for-life-science-companies-drivers-of-change/
NHS England will roll out online COVID-19 recovery portalPeople in the UK who are recovering from coronavirus infections will be able to get advice from an Share XNHS England will roll out online COVID-19 recovery portalhttps://pharmaphorum.com/news/nhs-england-will-roll-out-online-covid-19-recovery-portal/
